Jane Street’s Accelerate Diagnostics AXDX Stock Holding History

Jane Street’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,370	Closed	-$51K	–	9117
2022 Q3	$51K	Buy	+3,370	New	+$55.8K	﹤0.01%	8916
2021 Q1	–	Sell	-4,420	Closed	-$335K	–	9073
2020 Q4	$335K	Buy	+4,420	New	+$396K	﹤0.01%	6260
2019 Q2	–	Sell	-3,540	Closed	-$744K	–	5115
2019 Q1	$744K	Hold	3,540	–	–	﹤0.01%	3174
2018 Q4	$407K	Buy	+3,540	New	+$525K	﹤0.01%	3689

Other funds holding AXDX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street's AXDX Position: Q1 2025 in Review

Jane Street sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 22,415 shares — an estimated $26.9K sold.

Jane Street first reported a position in AXDX in Q2 2013 and held it in 13 quarters. The position peaked at $3.5M in Q4 2017. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.

Jane Street reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
Jane Street sold 22,415 Accelerate Diagnostics shares in Q1 2025, an estimated $26.9K.
Jane Street first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 13 quarters.
Jane Street's Accelerate Diagnostics position peaked at $3.5M in Q4 2017.
43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.